title: Complete staghorn calculi: random prospective comparison between extracorporeal shock wave lithotripsy monotherapy and combined with percutaneous nephrostolithotomy.
abstract: OBJECTIVE
  We determined the preferred treatment of staghorn calculi.
  
  
  METHODS
  Between January 1992 and December 1994 we performed a prospective, randomized, single center study involving 50 kidneys with complete staghorn calculi: 27 renal units were treated with extracorporeal shock wave lithotripsy (ESWL) monotherapy (group 1) and 23 were treated with combined (initial) percutaneous nephrostolithotomy with ESWL (group 2). The 2 treatment groups were compared regarding stone size, grade of collecting system dilatation and urine culture at presentation. The number of treatment sessions, narcotic doses, renal colic episodes, septic complications, unplanned ancillary procedures, length of hospitalization, total treatment duration and stone-free rate at 6 months were recorded and compared.
  
  
  RESULTS
  At the conclusion of therapy the stone-free rate was significantly greater in group 2 than in group 1 (74 versus 22%, respectively, p = 0.0005). The complication rate was significantly greater in group 1, with 15 septic complications (fever greater than 38.5C for longer than 3 days) in 10 patients compared to only 2 episodes in group 2 (p = 0.007). The unplanned ancillary procedure rate was significantly greater in group 1 (8 procedures in 7 patients versus 1 procedure in group 2, p = 0.03). The overall treatment length was significantly shorter in group 2 (1 versus 6 months, p = 0.0006). There was no significant difference in the number of procedures performed with anesthesia or in the number of hospitalization days between the 2 treatment groups.
  
  
  CONCLUSIONS
  Combined percutaneous nephrostolithotomy and ESWL should be recommended as the first line treatment choice for most patients with staghorn stones.
authors.affiliation: Department of Urology, Hadassah Medical Center, Jerusalem, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Meretyk
authors.forename: O N
authors.initials: ON
authors.lastname: Gofrit
authors.forename: O
authors.initials: O
authors.lastname: Gafni
authors.forename: D
authors.initials: D
authors.lastname: Pode
authors.forename: A
authors.initials: A
authors.lastname: Shapiro
authors.forename: A
authors.initials: A
authors.lastname: Verstandig
authors.forename: T
authors.initials: T
authors.lastname: Sasson
authors.forename: G
authors.initials: G
authors.lastname: Katz
authors.forename: E H
authors.initials: EH
authors.lastname: Landau
mesh_terms: D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000628:therapy*; D007670:Kidney Calices; D008096:Lithotripsy; D008297:Male; D008875:Middle Aged; D009403:Nephrostomy, Percutaneous; D011446:Prospective Studies